GO:0097500 receptor localization to non-motile cilium: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0097500 describes the biological process by which receptors are transported to, or maintained within, a non-motile cilium, a microtubule-based sensory organelle [1,2].
• Selective receptor targeting to the ciliary membrane is essential for sensing extracellular signals, including Sonic hedgehog (Shh), calcium, and G-protein-coupled receptor (GPCR) ligands [1,5].
• Disruption of receptor localization to non-motile cilia is linked to cystic kidney disease, Niemann-Pick type C1 disease, and Alzheimer's disease-related Shh signaling defects [2,3,6,8].
• Key proteins involved include somatostatin receptor 3 (SSTR3), Smoothened (SMO), polycystins (PKD1/PKD2), and intraflagellar transport (IFT) components [2,5].
• Research methods for studying this process include live-cell imaging of tagged receptors, ciliary proteomics, and CRISPR-based knockout or knock-in models [4,5].
• EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, and library screening services to dissect receptor localization mechanisms [1,2].
Description
Receptor localization to non-motile cilium (GO:0097500) is a specialized cellular process that ensures specific receptors are delivered to and retained within the membrane of a non-motile primary cilium. Non-motile cilia are antenna-like organelles that project from the surface of most mammalian cells and concentrate signaling receptors to detect extracellular cues [1,2]. The correct localization of receptors such as somatostatin receptor 3 (SSTR3) and Smoothened (SMO) to the ciliary membrane is critical for sensory transduction, including calcium signaling and Sonic hedgehog (Shh) pathway activation [1,5]. Defects in this process contribute to a spectrum of human diseases known as ciliopathies, including polycystic kidney disease and Niemann-Pick type C1 disease [2,3,6]. Understanding GO:0097500 therefore provides mechanistic insight into how cells organize signal detection and how its failure leads to pathology [2,8].
receptor localization to non-motile cilium At A Glance
| GO ID | GO:0097500 |
|---|---|
| GO term | receptor localization to non-motile cilium |
| Ontology | biological_process |
| Synonym | receptor localization to nonmotile primary cilium |
| Major function | Transport and retention of receptors within the non-motile cilium membrane |
| Related cellular component | Non-motile cilium (primary cilium) |
| Related molecular function | Receptor binding, protein transport, intraflagellar transport |
| Associated diseases | Polycystic kidney disease, Niemann-Pick type C1 disease, Alzheimer's disease |
What Is GO:0097500?
According to the Gene Ontology, GO:0097500 (receptor localization to non-motile cilium) is defined as the process in which a receptor is transported to, or maintained in, a location within a non-motile cilium. This encompasses both the active delivery of receptor proteins to the ciliary membrane and the mechanisms that retain them there, distinguishing it from general membrane trafficking.
Why Is receptor localization to non-motile cilium Important in Cell Biology?
Receptor localization to non-motile cilium is fundamental for cellular sensing and signal transduction, as the primary cilium acts as a signaling hub that concentrates receptors for Shh, calcium, and GPCR ligands [1,5]. Disruption of this process impairs development and tissue homeostasis, and is directly implicated in cystic kidney diseases, neurodegeneration, and developmental disorders [2,3,6,8]. Studying GO:0097500 helps researchers understand how cells decode extracellular signals and provides targets for therapeutic intervention in ciliopathies [2,7].
• Enables selective concentration of signaling receptors in the ciliary membrane for efficient signal detection.
• Required for Sonic hedgehog (Shh) signaling, which controls embryonic development and tissue patterning [6,8].
• Maintains calcium signaling microdomains that regulate cell proliferation and differentiation.
• Dysfunction leads to polycystic kidney disease through defective polycystin localization [2,3].
• Impaired receptor targeting contributes to Niemann-Pick type C1 disease pathology.
• Amyloid-beta disrupts primary cilia structure and Shh signaling, linking to Alzheimer's disease.
• Provides a model for studying membrane protein sorting and ciliary trafficking [4,5].
• Offers therapeutic targets for ciliopathies and related signaling disorders [2,7].
• Essential for neuronal cilia function and somatostatin receptor 3 signaling.
• Underpins the development of CRISPR-based disease models for ciliary receptor mislocalization [1,2].
What Happens During receptor localization to non-motile cilium?
Receptor recognition and cargo selection
In simple terms: The cell decides which receptors should go to the cilium.
Receptor localization begins with the recognition of specific ciliary targeting sequences (CTS) within the cytoplasmic tails of receptors such as SSTR3 and SMO. Adaptor proteins and small GTPases, including Arl6 and Rab8, recognize these motifs and package the receptors into vesicles destined for the ciliary base. This step ensures that only appropriate receptors are selected for ciliary delivery, a process critical for sensory function.
Vesicular transport to the ciliary base
In simple terms: Receptors are carried in bubbles to the foot of the cilium.
Selected receptors are transported from the Golgi or recycling endosomes to the base of the primary cilium via microtubule-dependent vesicular trafficking. The BBSome complex and intraflagellar transport (IFT) proteins coordinate the docking of these vesicles at the transition zone, a specialized membrane domain that gates entry into the cilium [2,3]. Defects in this transport step lead to receptor accumulation at the base and loss of ciliary signaling.
Intraflagellar transport and entry into the ciliary membrane
In simple terms: Molecular motors carry receptors up into the cilium.
Once at the ciliary base, receptors are loaded onto IFT trains and moved across the transition zone into the ciliary membrane. IFT-B particles mediated by kinesin-2 motors carry cargo anterogradely, while IFT-A and dynein-2 mediate retrograde transport. This active transport is essential for maintaining the ciliary membrane composition and for delivering receptors such as SMO during Shh signaling [6,8].
Retention and maintenance within the ciliary membrane
In simple terms: Receptors are kept in place once they arrive.
After delivery, receptors are retained in the ciliary membrane through interactions with the ciliary membrane diffusion barrier at the transition zone and through anchoring to the axoneme or associated protein complexes [1,2]. Maintenance of receptor localization requires continuous IFT and lipid composition, including cholesterol, which influences ciliary membrane dynamics. Loss of retention leads to receptor mislocalization and impaired signaling, as seen in ciliopathies [3,6].
Signal-dependent modulation of receptor localization
In simple terms: The cilium changes its receptor content in response to signals.
Receptor localization is dynamically regulated by extracellular signals; for example, Shh activation promotes SMO accumulation in the cilium while Patched1 exits [6,8]. Calcium signaling within the cilium can also feedback on receptor trafficking. This dynamic regulation ensures appropriate cellular responses to developmental and homeostatic cues [1,6].
Key Genes Involved in GO:0097500 receptor localization to non-motile cilium
The following genes encode proteins with established roles in receptor localization to non-motile cilium, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SSTR3 | Somatostatin receptor 3; a GPCR selectively targeted to neuronal cilia | Model for studying ciliary targeting sequences and neuronal signaling |
| SMO | Smoothened; key transducer of Shh signaling that accumulates in the cilium | Central to Shh pathway and ciliary receptor dynamics [6,8] |
| PKD1 | Polycystin-1; ciliary receptor involved in calcium signaling | Mutations cause autosomal dominant polycystic kidney disease [2,3] |
| PKD2 | Polycystin-2; ciliary calcium channel | Defective localization leads to cystic kidney disease [2,3] |
| IFT88 | Intraflagellar transport protein 88; essential for ciliary assembly and transport | Required for receptor delivery to cilia |
| BBS4 | BBSome component; involved in ciliary membrane protein trafficking | Mutations cause Bardet-Biedl syndrome with receptor mislocalization |
| ARL6 | Small GTPase; regulates ciliary membrane targeting | Key for BBSome-mediated receptor transport |
| RAB8A | GTPase; mediates vesicle docking at the ciliary base | Required for ciliary receptor delivery |
| NPHP1 | Nephrocystin-1; transition zone protein | Mutations affect ciliary gate and receptor localization |
| CC2D2A | Transition zone protein; part of ciliary gate | Defects cause Joubert syndrome with receptor trafficking defects |
| TTC21B | IFT-A component; retrograde transport | Mutations linked to ciliopathies and receptor mislocalization |
| DYNC2H1 | Dynein-2 heavy chain; retrograde IFT motor | Required for recycling ciliary components |
| KIF3A | Kinesin-2 motor subunit; anterograde IFT | Essential for ciliary receptor transport |
| NPC1 | Niemann-Pick C1 protein; cholesterol trafficking | Defective cilia and Shh signaling in Niemann-Pick disease |
| APP | Amyloid precursor protein; linked to Alzheimer's disease | Amyloid-beta disrupts cilia and Shh signaling |
How Is receptor localization to non-motile cilium Regulated?
Receptor localization to non-motile cilium is regulated by multiple mechanisms, including the BBSome complex, small GTPases (Arl6, Rab8), and intraflagellar transport. Cholesterol content in the ciliary membrane modulates receptor dynamics and is a therapeutic target in polycystic kidney disease. Additionally, Shh signaling feedback regulates SMO and Patched1 localization [6,8]. Calcium signaling within the cilium can also influence receptor trafficking.
receptor localization to non-motile cilium and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PKD1 | Autosomal dominant polycystic kidney disease | PKD1 knockout kidney organoids or mouse models [2,3] |
| PKD2 | Autosomal dominant polycystic kidney disease | PKD2 knockout cell lines and calcium imaging [2,3] |
| NPC1 | Niemann-Pick type C1 disease | NPC1 mutant fibroblasts and Shh reporter assays |
| APP | Alzheimer's disease | APP overexpression or amyloid-beta treated neuronal cultures |
| BBS4 | Bardet-Biedl syndrome | BBS4 knockout models with ciliary receptor tracking |
Polycystic kidney disease
Defective localization of polycystin-1 (PKD1) and polycystin-2 (PKD2) to the primary cilium disrupts calcium signaling and leads to cyst formation in autosomal dominant polycystic kidney disease [2,3]. Ciliary dysfunction is an emerging model for understanding the polarizing potential of kidney cells. Cholesterol in the ciliary membrane has been proposed as a therapeutic target for polycystic kidney disease.
Niemann-Pick type C1 disease
Mutations in NPC1 cause shortened primary cilia and dysregulated Sonic hedgehog signaling, partly due to impaired receptor localization within the cilium. This links cholesterol trafficking defects to ciliary signaling abnormalities in neurodegeneration.
Alzheimer's disease
Amyloid-beta interrupts canonical Sonic hedgehog signaling by distorting primary cilia structure, which affects receptor localization and downstream signaling. This provides a mechanistic link between Alzheimer's disease pathology and ciliary dysfunction.
Ciliopathies and developmental disorders
Mutations in IFT and BBSome components cause a spectrum of ciliopathies, including Bardet-Biedl syndrome and Joubert syndrome, characterized by mislocalization of ciliary receptors and impaired signaling. These disorders highlight the importance of GO:0097500 in development and tissue homeostasis.
From receptor localization to non-motile cilium-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene impair receptor delivery to cilia? | CRISPR knockout cell line (e.g., IFT88 KO) |
| Does a specific point mutation in a receptor affect ciliary targeting? | Point mutation knock-in via CRISPR |
| Can a tagged receptor be tracked in live cells? | Knock-in of fluorescent tag (e.g., SSTR3-GFP) |
| Does overexpression of a GTPase enhance ciliary receptor localization? | Overexpression cell model |
| Which genes regulate ciliary receptor composition? | CRISPR library screening |
| Does cholesterol modulation affect receptor retention? | Pharmacological treatment in wild-type and mutant cells |
How to Study the receptor localization to non-motile cilium Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell fluorescence microscopy | Receptor localization and dynamics in cilia | Tracking SSTR3-GFP in neurons |
| Immunofluorescence | Endogenous receptor co-localization with ciliary markers | Validating receptor localization in knockout cells |
| Ciliary proteomics | Protein composition of isolated cilia | Identifying novel ciliary receptors |
| RNA-seq | Transcriptional changes upon mislocalization | Shh target gene expression |
| Gli-luciferase reporter assay | Shh pathway activity | Functional consequence of receptor mislocalization [6,8] |
| Calcium imaging | Ciliary calcium signals | Linking receptor localization to calcium signaling |
| CRISPR screening | Genes required for receptor localization | Unbiased discovery of trafficking regulators |
Live-cell imaging of tagged receptors
Fluorescently tagged receptors, such as SSTR3-GFP, allow real-time visualization of receptor trafficking to and within the primary cilium. This method reveals dynamic changes in response to signals and is applicable to knockout or knock-in models.
Proteomics of isolated cilia
Isolation of primary cilia followed by mass spectrometry identifies the ciliary receptor repertoire and changes upon genetic perturbation. This approach can uncover novel components of the localization machinery.
Transcriptomics and RNA-seq
RNA sequencing of cells with disrupted ciliary trafficking reveals transcriptional changes downstream of receptor mislocalization, including altered Shh target genes [6,8].
Functional assays for Shh signaling
Shh pathway activation can be measured using Gli-luciferase reporters or by quantifying SMO accumulation in cilia after stimulation [6,8]. These assays link receptor localization to downstream signaling output [6,8].
How CRISPR Can Be Used to Study GO:0097500 receptor localization to non-motile cilium
Knockout
CRISPR knockout of genes such as IFT88 or BBS4 abolishes ciliary assembly or receptor trafficking, providing a clean background to study receptor localization defects. These models are essential for assigning causality to candidate genes.
Point Mutation
Introducing disease-associated point mutations (e.g., in PKD1 or NPC1) via CRISPR allows precise modeling of receptor mislocalization and signaling defects observed in patients [2,6].
Knock-in
Knock-in of fluorescent tags (e.g., SSTR3-GFP) or epitope tags enables real-time tracking of receptors in their native genomic context, revealing dynamic localization to non-motile cilia.
Overexpression
Overexpression of wild-type or mutant receptors and trafficking regulators (e.g., Rab8) can enhance or disrupt ciliary localization, helping to define sufficiency and dominant-negative effects.
How EDITGENE Supports receptor localization to non-motile cilium Research
Researchers studying receptor localization to non-motile cilium-related genes often need to determine whether a candidate gene is causally involved in receptor trafficking, retention, or signaling. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional interrogation of GO:0097500.
Contact EDITGENE today to design your custom CRISPR model for receptor localization to non-motile cilium research.
Frequently Asked Questions About receptor localization to non-motile cilium
What is receptor localization to non-motile cilium (GO:0097500)?
It is the biological process by which receptors are transported to or maintained within a non-motile cilium, ensuring proper sensory signaling [1,2].
What genes are involved in receptor localization to non-motile cilium?
Key genes include SSTR3, SMO, PKD1, PKD2, IFT88, BBS4, ARL6, and RAB8A, among others [2,5].
Why is receptor localization to non-motile cilium important?
It is essential for Shh signaling, calcium signaling, and neuronal function; defects cause ciliopathies and neurodegeneration [1,2,6].
What diseases are linked to defective receptor localization in cilia?
Polycystic kidney disease, Niemann-Pick type C1 disease, Alzheimer's disease, and Bardet-Biedl syndrome [2,3,6,8].
How do researchers study receptor localization to non-motile cilium?
Using live-cell imaging of tagged receptors, ciliary proteomics, RNA-seq, and CRISPR knockout or knock-in models [2,5].
What is the role of SSTR3 in ciliary receptor localization?
SSTR3 is a GPCR selectively targeted to neuronal cilia and serves as a model for studying ciliary targeting sequences.
How does cholesterol affect receptor localization to non-motile cilium?
Cholesterol in the ciliary membrane modulates receptor dynamics and is a therapeutic target in polycystic kidney disease.
Can CRISPR be used to study receptor localization to non-motile cilium?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools for dissecting this process [2,5].
What is the connection between primary cilia and calcium signaling?
Primary cilia concentrate calcium channels and receptors, creating microdomains that regulate signaling; receptor localization is key to this function.
How does amyloid-beta affect ciliary receptor localization?
Amyloid-beta distorts primary cilia structure and interrupts Shh signaling, affecting receptor localization.
Conclusion
Receptor localization to non-motile cilium (GO:0097500) is a fundamental process that positions signaling receptors within the primary cilium to detect extracellular cues. Its disruption underlies a range of human diseases, from cystic kidney disease to neurodegeneration [2,3,6,8]. Continued research using advanced CRISPR models and imaging will unravel the precise mechanisms and identify therapeutic targets [1,2,5].
References
- 1. Saternos H et al.. 2020. Primary Cilia and Calcium Signaling Interactions.. Int J Mol Sci 21(19) PMID: 32993148
- 2. Pazour GJ et al.. 2020. Cilia in cystic kidney and other diseases.. Cell Signal 69:109519 PMID: 31881326
- 3. Kolb RJ et al.. 2008. Ciliary dysfunction in polycystic kidney disease: an emerging model with polarizing potential.. Front Biosci 13:4451-66 PMID: 18508522
- 5. Händel M et al.. 1999. Selective targeting of somatostatin receptor 3 to neuronal cilia.. Neuroscience 89(3):909-26 PMID: 10199624
- 6. Canterini S et al.. 2017. Shortened primary cilium length and dysregulated Sonic hedgehog signaling in Niemann-Pick C1 disease.. Hum Mol Genet 26(12):2277-2289 PMID: 28379564
- 7. Morita T et al.. 2026. [Cholesterol in the ciliary membrane as a therapeutic target of polycystic kidney].. Nihon Yakurigaku Zasshi 161(3):171-176 PMID: 42091476
- 8. Vorobyeva AG et al.. 2018. Amyloid-β interrupts canonical Sonic hedgehog signaling by distorting primary cilia structure.. Cilia 7:5 PMID: 30140428
